News tagged with abbott laboratories

Fenofibrate / simvastatin benefit in dyslipidemia explored

(HealthDay)—Combination treatment with fenofibrate and simvastatin (FENO-S) significantly reduces postprandial (PP) triglyceride (TG) levels compared with simvastatin alone in all subjects, regardless of ...

Diabetes Nov 01, 2012 | 4.5 / 5 (2) | 0